Company Monitoring Page for Radius-Health

latest headlines for company on cafepharma

Radius, fending off activists, outlines pitch for $890 million buyout
BioPharma Dive
Fri, 07/8/22 - 10:44 am
Tags:
Radius Health, M&A, activists
VC firms take osteoporosis drugmaker Radius Health private for almost $900M
Endpoints
Mon, 06/27/22 - 10:04 am
Tags:
Radius Health, M&A, venture capital, osteoporosis
Radius falters after a PhIII osteoporosis fail and a breast cancer disappointment, sending shares plummeting
Endpoints
Thu, 12/9/21 - 10:56 am
Tags:
Radius Health, clinical trials, osteoporosis, breast cancer, Tymlos
Menarini, chased by 3 Big Pharmas, records win in breast cancer phase 3, plots path to FDA
Fierce Biotech
Thu, 10/21/21 - 10:35 am
Tags:
Menarini, Radius Health, breast cancer, clinical trials, Elacestrant
Validation for a drug class, and for Sanofi
EP Vantage
Wed, 05/12/21 - 10:44 am
Tags:
Sanofi, Serds, breast cancer, Amcenestrant, Radius Health, Elacestrant, Roche, Giredestrant, AstraZeneca, Camizestrant
Kelly Martin skips to a new CEO suite as his last biotech team raises the white flag
Endpoints
Thu, 04/30/20 - 10:36 am
Tags:
Kelly Martin, Pharma CEOs, Elan, Radius Health
Radius Health Initiates Phase III Trial of Osteoporosis Injection Drug for Males
CP Wire
Mon, 04/2/18 - 03:08 pm
Tags:
Radius Health, osteoporosis, men's health, Tymlos, clinical trials
EMA’s CHMP Rejects Two Drugs Approved by US FDA in 2017
RAPS.org
Fri, 03/23/18 - 10:10 am
Tags:
EMA, Europe, CHMP, FDA, Bevyxxa, Portola Pharmaceuticals, Dexxience, Tymlos, Radius Health, Eladynos
Payer coverage boosts Radius' Tymlos
BioPharma Dive
Fri, 08/4/17 - 11:40 am
Tags:
Radius Health, Tymlos, PBMs, Express Scripts, osteoporosis
Radius' Tymlos gets another big break as Express Scripts boots Lilly's Forteo
Fierce Pharma
Tue, 08/1/17 - 11:49 am
Tags:
Radius Health, Tymlos, Express Scripts, PBMs, formulary, Eli Lilly, Forteo, osteoporosis
An Endocrinologist Explains Her View Of Tymlos And The Osteoporosis Landscape
Seeking Alpha
Mon, 07/24/17 - 10:44 am
Tags:
Amgen, Radius Health, osteoporosis, Tymlos, romosozumab
FDA rejects Amgen’s osteoporosis drug romo as rival Radius surprises with a new CEO
Endpoints
Mon, 07/17/17 - 09:15 am
Tags:
FDA, Amgen, osteoporosis, romosozumab, UCB Pharma, Radius Health, Tymlos
Amgen's romosozumab red flag on heart safety means a boost for new Radius bone drug
Fierce Pharma
Mon, 05/22/17 - 09:45 am
Tags:
Amgen, romosozumab, Radius Health, UCB Pharma, Tymlos, osteoporosis
With Amgen hot on its heels, Radius races to get a jump on osteoporosis drug rivalry
Endpoints
Mon, 05/1/17 - 10:57 am
Tags:
Amgen, Radius Health, osteoporosis, Tymlos, romosozumab
FDA approves Radius Health's osteoporosis drug Tymlos
Yahoo/Reuters
Sat, 04/29/17 - 10:10 am
Tags:
FDA, Radius Health, osteoporosis, Tymlos
Radius shares slide after FDA delays decision on bone drug
BioPharma Dive
Fri, 03/10/17 - 09:03 pm
Tags:
Radius Health, FDA, abaloparatide, osteoporosis
Amgen’s expectations for romosozumab take a hit as Radius lines up its rival osteoporosis drug
Endpoints
Mon, 09/19/16 - 09:53 am
Tags:
Amgen, romosozumab, Radius Health, abaloparatide, osteoporosis
3 Biotech Stocks With Explosive Upside Potential
Motley Fool
Wed, 08/24/16 - 10:53 am
Tags:
Acadia, Nuplazid, Radius Health, abaloparatide-SC, Sarepta Therapeutics, eteplirsen
Split the pot? Radius shows its osteoporosis cards in final blockbuster match with Amgen
Endpoints
Wed, 08/17/16 - 10:38 am
Tags:
Amgen, Radius Health, osteoporosis, abaloparatide, romosozumab
5 Key FDA Decisions Expected in March
24/7 Wall St
Mon, 03/14/16 - 10:02 am
Tags:
FDA, Rayaldee, OPKO Health, Nuplazid, Acadia, abaloparatide, Radius Health, pegvaliase, Biomarin, ALD403, Alder Biopharmaceuticals

Pages

last 30 twitter posts

current feelings about your job

Please rate how you feel about your job this moment. 1 = "I hate my job" and 7 = "I love my job"
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Fill in the blank.